NervGen Pharma Corp. (NGEN)
2.07
-0.01
(-0.48%)
USD |
NASDAQ |
May 29, 16:00
2.06
-0.01
(-0.48%)
After-Hours: 20:00
NervGen Pharma Total Liabilities (Quarterly) : 10.91M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | 2.242M |
| Milestone Pharmaceuticals, Inc. | 157.68M |
| Manzo Pharmaceuticals, Inc. | -- |
| Clearmind Medicine, Inc. | 2.905M |
| Pharmagreen Biotech, Inc. | 9.943M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.88M |
| Shareholders Equity (Quarterly) | 3.971M |
| Current Ratio | 1.338 |
| Net Debt Paydown Yield | 0.00% |